Skip to main content
< Back to news
Photo: Board of Directors - © CataloniaBio & HealthTech, Anna Mas

CataloniaBio & HealthTech approves Strategic Plan 2021-2023 focused to enhance its projection in the biomedicine and healthcare sector

CataloniaBio & HealthTech members have given the green light to the Strategic Plan 2021-2023, which establishes the roadmap to consolidate the organisation and help the push to grow companies in the biomedicine and healthcare sector in Catalonia in size and projection over the next three years. The association, based in the Barcelona Science Park, has more than 180 member companies and leading knowledge stakeholders in R&D. This strategic plan is the result of months of reflection and working with companies and stakeholders in the ecosystem, carried out by LTC consultancy led by Xavier Marcet. The plan was presented today at the general assembly, explaining that CataloniaBio & HealthTech will work on four strategic focal points: strengthening the community, promoting a value-added cluster, projecting companies towards society and growing as the sector’s employers’ association. CataloniaBio & HealthTech has strengthened its executive team, bringing Judit Anido on board as CEO. Judit Anido has been a member of the Board of Directors since 2018 and has solid international experience as an executive, entrepreneur and scientist. In 2020, Anido was named president of CataloniaBio & HealthTech. Her move to a more executive role in the organisation coincides with the successful sale of the pipeline of Mosaic Biomedicals, the company she represented in the organisation, and its affiliate Northern Biologics to multinational pharmaceutical companies. Jaume Amat took over the presidency through the end of the current term of this board of directors. “It is very positive to be able to continue to count on Judit Anido’s leadership, at this time when we need to reinforce the team to tackle the big challenges and opportunities we are facing as an organisation and as a strategic sector for the future of Catalonia and Europe,” explains Jaume Amat. For her part, Judit Anido is very excited about this new era and wants to make CataloniaBio & HealthTech the business benchmark in the sector of biomedicine and healthcare in Catalonia, with great international projection. “Our strategy is twofold: to boost our place as the employers’ association that represents, defends and promotes the interests of the business fabric, and as a cluster that works to create value in the sector through innovation, entrepreneurship and networking. This is a historic moment in the sector and we have to make a firm commitment to growing and positioning ourselves as a comprehensive support organisation for the ecosystem,” explains.